Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. Joseph ReillySenior VP of Finance & Principal Accounting Officer | -3,72k | 23,31k | Verkauf | 6,27 | 149,84k | -2,42% |
| 2026-05-21 | Ms. Sue HohenleitnerCFO | -1,46k | 9,12k | Verkauf | 6,27 | 229,08k | -0,63% |
| 2026-05-21 | Dr. John E. BishopInsider | -2,31k | 14,45k | Verkauf | 6,27 | 336,85k | -0,68% |
| 2026-05-21 | Mr. James P. BradyChief HR Officer | -1,85k | 11,57k | Verkauf | 6,27 | 261,07k | -0,70% |
| 2026-05-21 | Mr. Eric Duane FosterChief Commercial Officer | -8,00k | 50,13k | Verkauf | 6,27 | 417,97k | -1,88% |
| 2026-05-21 | Mr. Mike KelliherChief Business Officer | -7,25k | 45,43k | Verkauf | 6,27 | 357,42k | -1,99% |
| 2026-05-21 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -6,99k | 43,80k | Verkauf | 6,27 | 429,09k | -1,60% |
| 2026-05-21 | Mr. Michael G. RaabPresident, CEO & Director | -54,75k | 343,13k | Verkauf | 6,27 | 1,75M | -3,04% |
| 2026-05-15 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 130,81k | Automatic Disposition | 6,28 | 1,80M | -1,14% |
| 2026-05-15 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 110,18k | Derivative Exercise and Sale | 0,99 - 6,28 | 1,80M | - |
| 2026-04-15 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 130,98k | Automatic Disposition | 6,29 | 1,82M | -1,13% |
| 2026-04-15 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 110,35k | Derivative Exercise and Sale | 0,99 - 6,29 | 1,82M | - |
| 2026-03-16 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 121,66k | Automatic Disposition | 5,84 | 1,84M | -1,12% |
| 2026-03-16 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 101,04k | Derivative Exercise and Sale | 0,99 - 5,84 | 1,84M | - |
| 2026-02-24 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 109,69k | Derivative Exercise and Sale | 0,99 - 6,26 | 1,86M | - |
| 2026-02-24 | Mr. Michael G. RaabPresident, CEO & Director | -20,83k | 130,31k | Automatic Disposition | 6,26 | 1,86M | -1,11% |
| 2026-02-20 | Mr. David M. MottIndependent Chairman of the Board | 333,33k | 1,95M | Kauf | 5,84 | 3,26M | 11,38% |
| 2026-02-20 | Dr. John E. BishopInsider | -3,18k | 18,59k | Verkauf | 5,70 - 5,87 | 214,82k | -1,46% |
| 2026-02-20 | Mr. Joseph ReillySenior VP of Finance & Principal Accounting Officer | -4,99k | 29,18k | Verkauf | 5,70 - 5,87 | 151,79k | -3,18% |
| 2026-02-20 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -8,18k | 47,80k | Verkauf | 5,71 - 5,87 | 436,08k | -1,84% |
| 2026-02-20 | Mr. James P. BradyChief HR Officer | -2,54k | 14,87k | Verkauf | 5,71 - 5,87 | 113,73k | -2,19% |
| 2026-02-20 | Ms. Sue HohenleitnerCFO | -2,03k | 11,89k | Verkauf | 5,71 - 5,87 | 230,53k | -0,87% |
| 2026-02-20 | Mr. Mike KelliherChief Business Officer | -9,60k | 56,10k | Verkauf | 5,71 - 5,87 | 364,67k | -2,56% |
| 2026-02-20 | Mr. Michael G. RaabPresident, CEO & Director | -45,98k | 268,84k | Verkauf | 5,70 - 5,87 | 1,88M | -2,38% |
| 2026-02-20 | Mr. Eric Duane FosterChief Commercial Officer | -10,44k | 61,03k | Verkauf | 5,70 - 5,87 | 425,97k | -2,39% |
| 2026-01-08 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -50,00k | 299,40k | Derivative Exercise and Sale | 0,99 - 6,98 | 361,56k | - |
| 2025-11-21 | Ms. Elizabeth A. GrammerInsider | -6,00k | 33,19k | Verkauf | 5,54 | 299,90k | -1,96% |
| 2025-11-21 | Mr. Michael G. RaabPresident, CEO & Director | -46,89k | 259,61k | Verkauf | 5,54 | 1,48M | -3,07% |
| 2025-11-21 | Mr. Mike KelliherChief Business Officer | -5,56k | 30,79k | Verkauf | 5,54 | 271,18k | -2,01% |
| 2025-11-21 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -6,43k | 35,58k | Verkauf | 5,54 | 359,90k | -1,75% |
| 2025-11-21 | Mr. Joseph ReillySenior VP of Finance & Principal Accounting Officer | -11,09k | 61,38k | Verkauf | 5,54 | 108,91k | -9,24% |
| 2025-11-21 | Mr. Eric Duane FosterChief Commercial Officer | -5,81k | 32,19k | Verkauf | 5,54 | 295,68k | -1,93% |
| 2025-08-21 | Mr. Mike KelliherChief Business Officer | -5,42k | 32,13k | Verkauf | 5,93 | 276,74k | -1,92% |
| 2025-08-26 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -50,00k | 256,55k | Derivative Exercise and Sale | 0,99 - 6,12 | 366,32k | - |
| 2025-08-26 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -30,00k | 183,63k | Verkauf | 6,12 | 366,32k | -7,57% |
| 2025-08-21 | Dr. Laura A. WilliamsChief Patient Officer & Interim Chief Medical Officer | -6,26k | 37,14k | Verkauf | 5,93 | 396,32k | -1,56% |
| 2025-08-21 | Mr. Justin A. RenzInsider | -7,04k | 41,74k | Verkauf | 5,93 | 409,05k | -1,69% |
| 2025-08-21 | Mr. Michael G. RaabPresident, CEO & Director | -45,69k | 271,00k | Verkauf | 5,93 | 1,53M | -2,90% |
| 2025-08-21 | Ms. Elizabeth A. GrammerInsider | -5,84k | 34,65k | Verkauf | 5,93 | 305,89k | -1,87% |
| 2025-08-21 | Mr. Eric Duane FosterChief Commercial Officer | -15,31k | 90,80k | Verkauf | 5,93 | 301,50k | -4,83% |
| 2025-06-16 | Mr. David M. MottIndependent Chairman of the Board | 200,00k | 725,88k | Kauf | 3,63 | 2,90M | 7,42% |
| 2025-06-09 | Mr. David M. MottIndependent Chairman of the Board | 200,00k | 737,26k | Kauf | 3,69 | 2,70M | 8,01% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
